Eczema cream put to the light test: will it cause skin reactions?

NCT ID NCT04361136

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This early-stage trial tested whether delgocitinib cream, a potential eczema treatment, makes skin more sensitive to light. Thirty-five healthy adults received a single application of the cream and a placebo on different skin spots, then were exposed to UV light. Researchers checked for redness, blisters, or other reactions to see if the cream could cause phototoxicity.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
delgocitinib cream

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bioskin Research Center Dermatology

    Hamburg, 20095, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.